N-METHYL-(R)-2-[(R)-2-(METHYLOXY)-1-(TERT.-BUTOXYCARBONYLAMINO)-2-OXO-ETHYL]-5-PHENYLPENTANOYL-(S)-PHENYLALANINEAMIDE
Compound with spectra: 1 NMR
![N-METHYL-(R)-2-[(R)-2-(METHYLOXY)-1-(TERT.-BUTOXYCARBONYLAMINO)-2-OXO-ETHYL]-5-PHENYLPENTANOYL-(S)-PHENYLALANINEAMIDE](/api/compound/2TC478a8CLs.png?ph=true&h=300&w=458 "N-METHYL-(R)-2-[(R)-2-(METHYLOXY)-1-(TERT.-BUTOXYCARBONYLAMINO)-2-OXO-ETHYL]-5-PHENYLPENTANOYL-(S)-PHENYLALANINEAMIDE")
| SpectraBase Compound ID | 2TC478a8CLs |
|---|---|
| InChI | InChI=1S/C29H39N3O6/c1-29(2,3)38-28(36)32-24(27(35)37-5)22(18-12-17-20-13-8-6-9-14-20)25(33)31-23(26(34)30-4)19-21-15-10-7-11-16-21/h6-11,13-16,22-24H,12,17-19H2,1-5H3,(H,30,34)(H,31,33)(H,32,36)/t22-,23+,24-/m1/s1 |
| InChIKey | TXMSZZITAWBFRW-TZRRMPRUSA-N |
| Mol Weight | 525.6 g/mol |
| Molecular Formula | C29H39N3O6 |
| Exact Mass | 525.283886 g/mol |
| Enantiomer InChIKey | TXMSZZITAWBFRW-VXNXHJTFSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
N-METHYL-(R)-2-[(R)-2-(HYDROXYAMINO)-1-(TERT.-BUTOXYCARBONYLAMINO)-2-OXO-ETHYL]-5-PHENYLPENTANOYL-(S)-PHENYLALANINEAMIDE
N-METHYL-(R)-2-[(R)-2-(BENZYLOXYAMINO)-1-(ACETYLAMINO)-2-OXO-ETHYL]-5-PHENYLPENTANOYL-(S)-PHENYLALANINEAMIDE
BENZYL-[(2R)-N-(TERT.-BUTOXYCARBONYL)-ALPHA-METHYL-ASPARTYL]-BETA-(2S)-PHENYLALANYL-BETA-ALANYL-[ALPHA-METHYL-(2R)-GLUTAMYL]-GAMMA-SARCOSINATE-TRIESTER;COMPOUN
UNNARMICIN_C
UNNARMICIN_A
CROTOGOSSAIDE;CYCLO-(-GLY-(1)-ALA-(2)-SER-(3)-GLY-(4)-LEU-(5)-ASN-(6)-GLY-(7)-ILE-(8)-PHE-(9)-)
TEOC-(3-NCP)ALA-PHE-VAL-OME
N-Benzyloxycarbonyl-2-trifluoromethyl.beta.-aspartyl-(.alpha.-methyl ester)-S-phenyl-alanine methyl ester
1962_B
CBZ-val-ser(TBDMS)-D-phe-ser(TBDMS)-ome
| Title | Journal or Book | Year |
|---|---|---|
| A Straightforward Approach to MMP-2 and MMP-9 Inhibitors Based on Chelate Claisen Rearrangements | European Journal of Organic Chemistry | 2011 |